Inspire Medical Systems, Inc. with ticker code (INSP) now have 16 analysts in total covering the stock. The consensus rating is pointing to ‘buy’. The range between the high target price and low target price is between $270.00 and $167.00 and has a mean target at $224.50. Given that the stocks previous close was at $187.33 this would imply there is now a potential upside of 19.8%. The 50 day moving average now sits at $154.27 and the 200 day moving average is $179.53. The company has a market cap of 5.70B. Currently the stock stands at: $191.23 USD
The potential market cap would be $6,834,353,152 based on the market consensus.
The company has a dividend yield of 2.05%. Other points of data to note are a P/E ratio of 910.62, revenue per share of $23.88 and a -1.33% return on assets.
Inspirit Energy Holdings PLC is a United Kingdom-based developer of micro-Combined Heat and Power (microCHP) boilers. The principal activity of the Company is that of an investment company that focuses on investing in disruptive products or technologies that are either proven or at the later stages of development, which own or have exclusive license to the relevant intellectual property. It also applies its expertise in the application of the Stirling engine technology in different sectors, including marine and waste heat recovery. It is also engaged in the development and commercialization of a microCHP boiler for use in commercial and residential markets. The microCHP boiler is powered by natural gas or hydrogen and designed to produce hot water (for domestic hot water or central heating) and a simultaneous electrical output that can be used locally or fed back into the national grid. Its Inspirit Charger can be installed as a standalone, or as the lead appliance in a plant room.
